Comparison of outcomes of transurethral prostate resection in urodynamically obstructed versus selected urodynamically unobstructed or equivocal men

Urology

Volumn 62, Issue 4, 2003, Pages 672-676

  Van Venrooij, Ger E P M ^a   Van Melick, Harm H E ^a   Boon, Tom A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLADDER NECK STENOSIS; COMPARATIVE STUDY; EVALUATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RESIDUAL URINE; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URETHRA STENOSIS; URINE FLOW RATE; URODYNAMICS;

EID: 0141449255     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00511-9     Document Type: Article

References (11)

1. Abrams P. New words for old lower urinary tract symptoms for "prostatism" BMJ. 308:1994;929-930.
2. Recommendations of the International Scientific Committee: Evaluation and treatment of lower urinary tract symptoms (LUTS) in older men, in Chatelain C, Denis L, Foo KT, et al (Eds): Benign Prostatic Hyperplasia: 5th International Consultation on Benign Prostatic Hyperplasia (BPH). Plymouth, UK, Plymbridge Distributors, 2001, pp 519-534.
3. Barry M.J., Fowler F.J. Jr, O'Leary M.P., et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 148:1992;1549-1557.
4. Barry MJ, Fowler FJ Jr, O'Leary MP, et al, for the Measurement Committee of the American Urological Association: Measuring disease-specific health status in men with benign prostatic hyperplasia. Med Care 33(4 suppl): AS145-AS155, 1995.
5. Abrams P, Griffiths D, Höfner K, et al: The urodynamic assessment of lower urinary tract symptoms, in Chatelain C, Denis L, Foo KT, et al (Eds): Benign Prostatic Hyperplasia: 5th International Consultation on Benign Prostatic Hyperplasia (BPH). Plymouth, UK, Plymbridge Distributors, 2001, pp 227-281.
6. van Venrooij G.E., van Melick H.H., Eckhardt M.D., et al. Correlations of urodynamic changes with changes in symptoms and well-being after transurethral resection of the prostate. J Urol. 168:2002;605-609.
7. Griffiths D.J., Höfner K., van Mastrigt R., et al. Standardization of terminology of lower urinary tract function pressure-flow studies of voiding, urethral resistance and urethral obstruction . Neurourol Urodyn. 16:1997;1-18.
8. Griffiths D., van Mastrigt R., Bosch R. Quantification of urethral resistance and bladder function during voiding, with special reference to the effects of prostate size reduction on urethral obstruction due to benign prostatic hyperplasia. Neurourol Urodyn. 8:1989;17-27.
9. Wilt T.J., Howe W., MacDonald R. Terazosin for treating symptomatic benign prostatic obstruction a systematic review of efficacy and adverse effects . BJU Int. 89:2002;214-225.
10. Witjes W.P., Rosier P.F., Caris C.T., et al. Urodynamic and clinical effects of terazosin therapy in symptomatic patients with and without bladder outlet obstruction a stratified analysis. Urology. 49:1997;197-205.
11. Holtgrewe HL: Current trends in management of men with lower urinary tract symptoms and benign prostatic hyperplasia. Urology 51(4A suppl): 1-7, 1998.